Ultrafast and high-throughput mass spectrometric assay for therapeutic drug monitoring of antiretroviral drugs in pediatric HIV-1 infection applying dried blood spots

Kaletra® (Abott Laboratories) is a co-formulated medication used in the treatment of HIV-1-infected children, and it contains the two antiretroviral protease inhibitor drugs lopinavir and ritonavir. We validated two new ultrafast and high-throughput mass spectrometric assays to be used for therapeut...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Meesters, Roland J. W., van Kampen, Jeroen J. A., Reedijk, Mariska L., Scheuer, Rachel D., Dekker, Lennard J. M., Burger, David M., Hartwig, Nico G., Osterhaus, Albert D. M. E., Luider, Theo M., Gruters, Rob A.
Format: Artigo
Idioma:Inglês
Publicat: Springer-Verlag 2010
Matèries:
Original Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2919689/
https://ncbi.nlm.nih.gov/pubmed/20632164
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00216-010-3952-9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars